בליאומיצין PFI Israel - hebreo - Ministry of Health

בליאומיצין pfi

megapharm ltd - bleomycin sulfate - אבקה להכנת תמיסה לזריקה - bleomycin sulfate 15000 iu/vial - bleomycin - bleomycin - bleomycin is useful in the management of the following neoplasms: squamous cell carcinoma affecting the mouth, nasopharynx and paranasal sinuses, larynx, oesaphagus, cervix, vagina, penis and skin. well differentiated tumors usually respond better than anaplastic ones.hodgkin's disease and other malignant lymphomas, including mycosis fungoides. testicular carcinoma (seminoma and no seminoma) .malignant effusions of serous cavities (intrapleural and intraperitoneal).secondary indications in which bleomycin has been shown to be of some value include metastatic malignant melanoma, carcinoma of the thyroid lung and bladder. local treatment of refractory warts. bleomycin can be used as a single agent, but is generally used in combination with other cytotoxics and/or with radiation therapy.

קלרידקס Israel - hebreo - Ministry of Health

קלרידקס

dexcel ltd, israel - clarithromycin - קפליות - clarithromycin 250 mg - clarithromycin - clarithromycin - klaridex is indicated in the treatment of infections caused by one or more susceptible organisms. indications include: lower respiratory tract infections, for example, acute and chronic bronchitis and pneumonia. upper respiratory tract infections, for example, sinusitis and pharyngitis. klaridex is appropriate for initial therapy in community acquired respiratory infections and has been shown to be active in vitro against common and atypical respiratory pathogens as listed in the microbiology section. klaridex is also indicated in skin and soft tissue infections of mild to moderate severity. klaridex is also indicated in combination with proton pump inhibitor for the eradication of h. pylori in patients with proven duodenal ulcer. treatment of mycobacterium avium complex infection in aids patients.

יומירה Israel - hebreo - Ministry of Health

יומירה

abbvie biopharmaceuticals ltd, israel - adalimumab - תמיסה להזרקה - adalimumab 100 mg / 1 ml - adalimumab

היירימוז Israel - hebreo - Ministry of Health

היירימוז

novartis israel ltd - adalimumab - תמיסה להזרקה - adalimumab 50 mg/ml - adalimumab

יופלימה Israel - hebreo - Ministry of Health

יופלימה

padagis israel agencies ltd, israel - adalimumab - תמיסה להזרקה - adalimumab 100 mg/ml - adalimumab

דיפלוקאן 200 מ"ג/5 מ"ל Israel - hebreo - Ministry of Health

דיפלוקאן 200 מ"ג/5 מ"ל

pfizer pharmaceuticals israel ltd - fluconazole 200 mg / 5 ml - powder for suspension - fluconazole - cryptoccosis including cryptoccocal meningitis, systemic candidiasis including candidemia, mucosal candidiasis, vaginal candidiasis, dermatomycosis all as specified in leaflet.

דיפלוקאן 50 מג5 מל Israel - hebreo - Ministry of Health

דיפלוקאן 50 מג5 מל

pfizer pfe pharmaceuticals israel ltd - fluconazole - אבקה להכנת תרחיף - fluconazole 50 mg / 5 ml - fluconazole - fluconazole - cryptoccosis including cryptoccocal meningitis, systemic candidiasis including candidemia, mucosal candidiasis, vaginal candidiasis, dermatomycosis all as specified in leaflet.

לוסק 10 מ"ג Israel - hebreo - Ministry of Health

לוסק 10 מ"ג

abic ltd. - omeprazole 10.0 mg - capsules - omeprazole - - acute duodenal ulcer. - acute gastric ulcer. - helicobacter pylori-associated peptic ulcer disease in combination with antibiotics. - reflux esophagitis:• treatment;• long-term management;• maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. - severe reflux esophagitis in children from one year of age and older • maintenance treatment for the prevention of relapse in patients with poorly responsive peptic ulcer.• zollinger-ellison syndrome.• treatment and prevention of nsaid – associated duodenal and gastric ulcers or erosions in high risk patients.

לוסק 10 מ"ג Israel - hebreo - Ministry of Health

לוסק 10 מ"ג

abic ltd. - omeprazole 10.0 mg - capsules - omeprazole - - acute duodenal ulcer. - acute gastric ulcer. - helicobacter pylori-associated peptic ulcer disease in combination with antibiotics. - reflux esophagitis:• treatment;• long-term management;• maintenance treatment for the prevention of relapse in patients with severe reflux esophagitis. - severe reflux esophagitis in children from one year of age and older • maintenance treatment for the prevention of relapse in patients with poorly responsive peptic ulcer.• zollinger-ellison syndrome.• treatment and prevention of nsaid – associated duodenal and gastric ulcers or erosions in high risk patients.

אורפדין 2 מג קפסולות קשות Israel - hebreo - Ministry of Health

אורפדין 2 מג קפסולות קשות

megapharm ltd - nitisinone - קפסולה קשיחה - nitisinone 2 mg - nitisinone - nitisinone - treatment of patients with confirmed diagnosis of hereditary tyrosinemia type 1 (ht-1) in combination with dietary restriction of tyrosine and phenylalanine